Aflac
About: Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.
Employees: 12,785
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
165% more first-time investments, than exits
New positions opened: 188 | Existing positions closed: 71
82% more call options, than puts
Call options by funds: $562M | Put options by funds: $309M
67% more funds holding in top 10
Funds holding in top 10: 18 [Q2] → 30 (+12) [Q3]
17% more capital invested
Capital invested by funds: $35.9B [Q2] → $41.9B (+$5.95B) [Q3]
7% more funds holding
Funds holding: 1,420 [Q2] → 1,521 (+101) [Q3]
3.92% less ownership
Funds ownership: 70.93% [Q2] → 67.01% (-3.92%) [Q3]
20% less repeat investments, than reductions
Existing positions increased: 464 | Existing positions reduced: 581
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
Wells Fargo Elyse Greenspan 67% 1-year accuracy 70 / 105 met price target | 2%downside $104 | Equal-Weight Maintained | 14 Jan 2025 |
Keefe, Bruyette & Woods Ryan Krueger 94% 1-year accuracy 16 / 17 met price target | 0%upside $107 | Market Perform Maintained | 10 Jan 2025 |
JP Morgan Jimmy Bhullar 51% 1-year accuracy 19 / 37 met price target | 12%downside $94 | Neutral Maintained | 7 Jan 2025 |
Barclays Alex Scott 56% 1-year accuracy 38 / 68 met price target | 8%downside $98 | Underweight Maintained | 6 Jan 2025 |
Evercore ISI Group Thomas Gallagher 60% 1-year accuracy 9 / 15 met price target | 4%downside $102 | Underperform Maintained | 4 Dec 2024 |
Financial journalist opinion
Based on 7 articles about AFL published over the past 30 days
